Incontinence, Urinary: Clinical Trials

2 trials for Incontinence, Urinary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2

Follow Incontinence, Urinary: new trials by email Literature Review of Incontinence, Urinary trials Research Report on Incontinence, Urinary

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TReating Incontinence for Underlying Mental and Physical Health
Tolterodine Tartrate ER, Mirabegron, Placebo - Urinary Incontinence, Urge, Urinary Incontinence
Phase 4RecruitingUniversity of California, San Francisco2702022-10-042026-03-06
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
OnabotulinumtoxinA 100 UNT - Urinary Bladder, Overactive, Incontinence, Urge
Phase 4RecruitingUniversity of South Florida602019-10-092020-11-05

Narrower conditions

Urinary Bladder, Overactive (2)  ·  Urinary Incontinence (2)  ·  Urinary Incontinence, Urge (2)  ·  Nocturia (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Lower Urinary Tract Symptoms (2)  ·  Male Urogenital Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Urinary Bladder Diseases (2)  ·  Urination Disorders (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Urological Manifestations (2)

Interventions

Botulinum Toxins, Type A (1)  ·  Tolterodine Tartrate (1)  ·  mirabegron (1)

Sponsors

University of California, San Francisco (1)  ·  University of South Florida (1)

Countries

United States (2)

Top investigators

Alison Huang, MD, MAS, MPhil (1)  ·  Eric S Chang, MD (1)

Results publications

PMID 35543540, PMID 37085880

NIH funding

R01AG075471 (1)